Physician profile
Bradley M Lane
NPI 1255539607
$6,236.59
in general payments reported to CMS, 2019-2025
21 companies · $701 in 2025
The $701 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $840 · 2020: $501 · 2021: $703 · 2022: $624 · 2023: $610 · 2024: $2,257 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,444 · Consulting Fee: $900 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,443.86 |
| Consulting Fee | $900.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $225.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $1,371.51 | 2024 | |
| Alcon Vision LLC | $1,026.91 | 2019-2025 | Precision7, Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $854.04 | 2022-2025 | Infuse, Miebo, Xiidra |
| Coopervision INC. | $709.79 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Biofinity Contact Lens |
| Lkc Technologies, INC. | $318.86 | 2022-2024 | |
| Maculogix, INC. | $279.83 | 2020-2021 | |
| Allergan, INC. | $257.07 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $229.61 | 2019-2021 | |
| Abbvie INC. | $202.03 | 2022 | |
| Novartis Pharmaceuticals Corporation | $161.63 | 2019-2022 | |
| Topcon Healthcare, INC. | $161.46 | 2025 | |
| Glaukos Corporation | $143.76 | 2024 | Radius |
| Optovue, INC. | $78.94 | 2020 | |
| Penumbra, INC. | $73.44 | 2019 | |
| Aerie Pharmaceuticals, INC. | $67.72 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $65.96 | 2019 | |
| Dompe US, INC. | $58.47 | 2024-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $57.47 | 2021-2023 | Cequa |
| Johnson & Johnson Vision Care, INC. | $53.51 | 2019 | |
| Astellas Pharma US INC | $45.18 | 2024 | Izervay |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.